# Roivant Sciences (ROIV) — Overview

ROIV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/roiv

## Price

Last close $34.04 on Oct 15, 2026. 52-week range $16.99 – $41.81.

## Company profile

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $7.5M |
| Revenue (quarter) | $1.4M |
| Revenue growth (year over year) | -33.55% |
| Gross profit (trailing twelve months) | $6.1M |
| Gross margin | 81.21% |
| Net income (trailing twelve months) | −$414.6M |
| Net income (quarter) | −$290.6M |
| Net income growth (year over year) | -6.10% |
| Net margin | -5504.54% |
| Return on equity | -6.21% |
| EPS (trailing twelve months) | −$0.36 |
| Book value per share | $5.86 |
| P/E (trailing twelve months) | — |
| Price to book | 5.0 |
| Debt to assets | 7.25% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Roivant Sciences (ROIV) profitable?

No. Roivant Sciences reported a net loss of $414.6M over the trailing twelve months.

### How much revenue does Roivant Sciences (ROIV) make?

Roivant Sciences generated $7.5M in revenue over the trailing twelve months, down 33.55% year over year.

### How do I buy stock in Roivant Sciences (ROIV)?

ROIV trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).